Atlas Trials

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

Clinical trial NCT03747042 · COMPLETED

Trial details

NCT number
NCT03747042
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer Female
Start date
2018-11-27
Primary completion
2025-02-24
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.